EGFR and neoplasm: Moreover, a study conducted by Guo et al. analyzed 120 single tumor cells and confirmed the intratumor heterogeneity of EGFR-activating mutations in lung adenocarcinoma on the single-cell level, which might closely relate to EGFR-TKIs response in lung adenocarcinoma patients [16, 18–20].